# Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer

> **NCT00075413** · PHASE2 · WITHDRAWN · sponsor: **The University of Texas Medical Branch, Galveston**

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** arsenic trioxide

## Key facts

- **NCT ID:** NCT00075413
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2002-11
- **Primary completion:** 2005-07
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to identify qualified subjects willing to participate in this study
- **Last updated:** 2015-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075413, "Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00075413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*